Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|April 1, 1982
Gentamicin does not chelate calciumS J Kohlhepp, S B Plant, D A McCarron, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1986
Modification of experimental aminoglycoside nephrotoxicityW M Bennett, C A Wood, D C Houghton, et al.
Southern Medical Journal|September 1, 1989
Human immunodeficiency virus: risk of exposure among health care workers at a southern urban hospitalG F Risi, R H Gaumer, S Weeks, et al.
The American Journal of Medicine|November 29, 1985
Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult womenC V Sanders, R L Marier, K E Aldridge, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistanceK E Aldridge, A Henderberg, K Gebbia, et al.
Lupus|April 7, 1999
Systemic lupus erythematosus complicated by necrotizing fasciitisE A Mendez, L M Espinoza, M Harris, et al.
Southern Medical Journal|April 1, 1979
Intravenous metronidazole therapy for Bacteroides fragilis meningitisC S Bryan, L J Huffman, V E Del Bene, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Moxalactam in the therapy of serious infectionsR L Marier, S Faro, C V Sanders, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1982
Gentamicin nephrotoxicity. II. Definition of conditions necessary to induce acquired insensitivityW C Elliott, D C Houghton, D N Gilbert, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicityS K Swan, D N Gilbert, S J Kohlhepp, et al.
Pageof 14